questionText: To ask the Secretary of State for Health and Social Care, with reference to the Answer of 14 April 2026 to Question 127101 on Cancer: Vaccination, (a) (i) how many and (ii) which pharmaceutical companies attended the NHS England webinar in 2025, and (b) (i) how many and (ii) which pharmaceutical companies have since expressed an interest in working with the Cancer Vaccine Launch Pad.
answerText: The Cancer Vaccine Launch Pad (CVLP) is a platform that is increasing access and speeding up recruitment to clinical trials for personalised cancer vaccines and other immunotherapies for patients who have been diagnosed with cancer. In 2025, the scope of ...
heading: Cancer: Vaccination